Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized single-blind phase II trial of dextralansoprazole injection for bleeding peptic ulcers
CTR20170225Phase 2Completed
- Sponsor
- Nanjing Youke Pharmaceutical
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexlansoprazole in upper gastrointestinal bleeding (UGIB), Peptic ulcer disease (PUD), sponsored by Nanjing Youke Pharmaceutical. Started Jul 2017; status: completed.
02
Drugs
dexlansoprazole
03
Conditions
upper gastrointestinal bleeding (UGIB)Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on CTR20170225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170225.